📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation. (2016)

First Author: Ang JE

Attributed to: Effect of the circadian clock time of day and sleep on the human metabolome: identification of metabolite rhythms funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1535-7163.mct-15-0815

PubMed Identifier: 27048952

Publication URI: http://europepmc.org/abstract/MED/27048952

Type: Journal Article/Review

Volume: 15

Parent Publication: Molecular cancer therapeutics

Issue: 6

ISSN: 1535-7163